Stephen Ooi – Senior Executive Advisor, Asia Pacific, Zimmer Biomet, Singapore

In an exclusive interview with Stephen Ooi, Senior Executive Advisor at Zimmer Biomet, he emphasizes the strategic benefits of the global merger between Zimmer and Biomet and how through leveraging their synergies, Zimmer Biomet will continue to raise the standards of quality and take an active role in bringing musculoskeletal solutions to the region.  
Biomet brings capabilities and products to Zimmer’s portfolio that strengthens our place in the musculoskeletal area. Moreover, the merger brings together a strong fusion of quality talent that benefits the company overall
Become a PharmaBoardroom Member for free to access this content
Join the 20,000+ pharmaceutical professionals who already subscribe to PharmaBoardroom
Register
Already a member? Sign In

Related Interviews

Latest Report